"The Voice of Oncology in Massachusetts"

Contact Us    |      Join    |

Pfizer's ELREXFIO (elranatamab-bccm) Has Been Assigned a Healthcare Common Procedure Coding System (HCPCS)* J-Code

April 02, 2024 8:36 AM | Katy Monaco

Effective for dates of service on or after April 1, 2024, the Centers for Medicare and Medicaid Services (CMS) has assigned the following Healthcare Common Procedure Coding System (HCPCS)* J-Code for ELREXFIO (elranatamab-bccm) injection:

J1323- Injection, elranatamab-bcmm, 1 mg

Please see full prescribing information including Boxed Warning, HERE.


ADDRESS

860 Winter Street, Waltham, MA, 02451

CONTACT US

tel: 781.434.7316

msco@mms.org

Massachusetts Society of Clinical Oncologists ©2024

Powered by Wild Apricot Membership Software